To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05467800
Title Study of Canakinumab in Patients With Myelofibrosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors John Mascarenhas
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona ACTIVE_NOT_RECRUITING Phoenix Arizona 85259 United States Details
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute ACTIVE_NOT_RECRUITING Los Angeles California 90048 United States Details
Moffitt Cancer Center ACTIVE_NOT_RECRUITING Tampa Florida 33612 United States Details
The University of Kansas Cancer Center-Westwood ACTIVE_NOT_RECRUITING Westwood Kansas 66205 United States Details
Ruttenberg Treatment Center RECRUITING New York New York 10029 United States Details
Wake Forest Baptist Health Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Foundation ACTIVE_NOT_RECRUITING Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field